CR3L3_HUMAN - dbPTM
CR3L3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CR3L3_HUMAN
UniProt AC Q68CJ9
Protein Name Cyclic AMP-responsive element-binding protein 3-like protein 3
Gene Name CREB3L3
Organism Homo sapiens (Human).
Sequence Length 461
Subcellular Localization Endoplasmic reticulum membrane
Single-pass type II membrane protein .
Processed cyclic AMP-responsive element-binding protein 3-like protein 3: Nucleus. Under ER stress the cleaved N-terminal cytoplasmic domain translocates into the nucleus.
Protein Description Transcription factor that may act during endoplasmic reticulum stress by activating unfolded protein response target genes. Activated in response to cAMP stimulation. In vitro, binds to the cAMP response element (CRE) and box-B element. Activates transcription through box-B element. Activates transcription through CRE (By similarity). Seems to function synergistically with ATF6. In acute inflammatory response, may activate expression of acute phase response (APR) genes. May be involved in growth suppression..
Protein Sequence MNTDLAAGKMASAACSMDPIDSFELLDLLFDRQDGILRHVELGEGWGHVKDQQVLPNPDSDDFLSSILGSGDSLPSSPLWSPEGSDSGISEDLPSDPQDTPPRSGPATSPAGCHPAQPGKGPCLSYHPGNSCSTTTPGPVIQVPEASVTIDLEMWSPGGRICAEKPADPVDLSPRCNLTVKDLLLSGSSGDLQQHHLGASYLLRPGAGHCQELVLTEDEKKLLAKEGITLPTQLPLTKYEERVLKKIRRKIRNKQSAQESRKKKKEYIDGLETRMSACTAQNQELQRKVLHLEKQNLSLLEQLKKLQAIVVQSTSKSAQTGTCVAVLLLSFALIILPSISPFGPNKTESPGDFAPVRVFSRTLHNDAASRVAADAVPGSEAPGPRPEADTTREESPGSPGADWGFQDTANLTNSTEELDNATLVLRNATEGLGQVALLDWVAPGPSTGSGRAGLEAAGDEL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
109PhosphorylationPRSGPATSPAGCHPA
CCCCCCCCCCCCCCC
18.1724275569
173PhosphorylationPADPVDLSPRCNLTV
CCCCCCCCCCCCCCH
13.0622171320
200PhosphorylationQQHHLGASYLLRPGA
HHHHCCCCEEECCCC
17.9524719451
223UbiquitinationTEDEKKLLAKEGITL
CHHHHHHHHHCCCCC
9.81-
225UbiquitinationDEKKLLAKEGITLPT
HHHHHHHHCCCCCCC
57.34-
229PhosphorylationLLAKEGITLPTQLPL
HHHHCCCCCCCCCCC
37.23-
256PhosphorylationRKIRNKQSAQESRKK
HHHHCHHHHHHHHHH
33.2617924679
260PhosphorylationNKQSAQESRKKKKEY
CHHHHHHHHHHHHHH
37.0017924679
267PhosphorylationSRKKKKEYIDGLETR
HHHHHHHHHHHHHHH
17.12-
273PhosphorylationEYIDGLETRMSACTA
HHHHHHHHHHHHHHH
36.39-
276PhosphorylationDGLETRMSACTAQNQ
HHHHHHHHHHHHHHH
19.53-
294AcetylationRKVLHLEKQNLSLLE
HHHHHHHHHCHHHHH
51.3430587873
347O-linked_GlycosylationSPFGPNKTESPGDFA
CCCCCCCCCCCCCCC
48.62OGP
347PhosphorylationSPFGPNKTESPGDFA
CCCCCCCCCCCCCCC
48.6223879269
379PhosphorylationAADAVPGSEAPGPRP
HHHCCCCCCCCCCCC
25.2329759185
379O-linked_GlycosylationAADAVPGSEAPGPRP
HHHCCCCCCCCCCCC
25.2322171320
410N-linked_GlycosylationWGFQDTANLTNSTEE
CCCCCCCCCCCCHHH
49.87UniProtKB CARBOHYD
413N-linked_GlycosylationQDTANLTNSTEELDN
CCCCCCCCCHHHHHH
50.5320356926
420N-linked_GlycosylationNSTEELDNATLVLRN
CCHHHHHHCEEEECC
47.6620356926
427N-linked_GlycosylationNATLVLRNATEGLGQ
HCEEEECCCCCCCCE
47.2320356926
449PhosphorylationAPGPSTGSGRAGLEA
CCCCCCCCCCHHHHH
25.7929759185

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CR3L3_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
294Kubiquitylation

30389664

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CR3L3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
ZHANG_HUMANCREBZFphysical
21994947
CR3L1_HUMANCREB3L1physical
23661758
CR3L3_HUMANCREB3L3physical
23661758
CREB3_HUMANCREB3physical
23661758
IMA1_HUMANKPNA2physical
21988832
RIOK3_HUMANRIOK3physical
21988832
KHDR1_HUMANKHDRBS1physical
21988832
PELI2_HUMANPELI2physical
21988832
PRGC1_HUMANPPARGC1Aphysical
21994947
FBW1A_HUMANBTRCphysical
26108621
FBW1A_HUMANBTRCphysical
27029215
CUL1_HUMANCUL1physical
27029215
RBX1_HUMANRBX1physical
27029215

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CR3L3_HUMAN

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"N-linked glycosylation is required for optimal proteolytic activationof membrane-bound transcription factor CREB-H.";
Chan C.P., Mak T.Y., Chin K.T., Ng I.O., Jin D.Y.;
J. Cell Sci. 123:1438-1448(2010).
Cited for: GLYCOSYLATION AT ASN-413; ASN-420 AND ASN-427.
O-linked Glycosylation
ReferencePubMed
"Human urinary glycoproteomics; attachment site specific analysis ofN-and O-linked glycosylations by CID and ECD.";
Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.;
Mol. Cell. Proteomics 0:0-0(2011).
Cited for: GLYCOSYLATION AT SER-379, STRUCTURE OF CARBOHYDRATES, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-256 AND SER-260, ANDMASS SPECTROMETRY.

TOP